Photodynamic therapy: A promising new modality for the treatment of cancer

Journal of Photochemistry and Photobiology B: Biology

Volumn 34, Issue 1, 1996, Pages 3-12

  Schuitmaker, J J ^a   Baas, P ^b   Van Leengoed, H L L M ^c   Van Der Meulen, F W ^d   Star, W M ^e   Van Zandwijk, N ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

5 aminolevulinic acid; Cancer; Photodynamic therapy; Photofrin ; Photosensitizers

Indexed keywords

AMINOLEVULINIC ACID; DIHEMATOPORPHYRIN ESTER; PHOTOFRIN; PHOTOSENSITIZING AGENT; TETRAPHENYLPORPHINESULFONIC ACID;

BLADDER CANCER; CANCER; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARYNX CANCER; LUNG CANCER; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN DISEASE; SMOOTH MUSCLE SPASM; SOLID TUMOR; TOPICAL DRUG ADMINISTRATION;

EID: 0030174907     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/1011-1344(96)07342-3     Document Type: Article

References (99)

1. [1] T.J. Dougherty, W.R. Potter and D. Bellnier, Photodynamic therapy for the treatment of cancer: Current status and advances, In D. Kessel (ed.), Photodynamic Therapy of Neoplastic Disease (Vol. 1), CRC Press, Boca Raton, FL, 1990, pp. 1-19.
2. [2] R.S. Wooten, K.C. Smith and D.A. Ahlquist, Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative, Lasers Surg. Med., 8 (1988) 294-300.
3. [3] V.M. Mullooly, A.L. Abramson and M.J. Shikowitz, Dihematoporphyrin-ether induced photosensitivity in laryngeal papilloma patients, Lasers Surg. Med., 10 (1990) 349-356.
4. [4] N. Razum, O.J. Balchum, A.E. Profio et al., Skin photosensitivity: Duration and intensity following intravenous hematoporphyrin derivatives, HPD and DHE, Photochem. Photobiol., 46 (1987) 925-928.
5. [5] S. Lam, B. Palcic, D. McLean et al., Detection of early lung cancer using low dose Photofrin II, Chest, 97 (1990) 333-337.
6. [6] B.D. Wilson, T.S. Mang, H. Stoll, C. Jones, M. Cooper and T.J. Dougherty, Photodynamic therapy for the treatment of basal cell carcinoma, Arch. Dermatol., 128 (1992) 1597-1601.
7. [7] J.C. Kennedy and R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol., 14 (1991) 275-292.
8. [8] A.M.R. Fisher, A.L. Murphree and C.J. Gomer, Clinical and preclinical photodynamic therapy, Rev. Ser., Lasers Surg. Med., 17 (1995) 2-31.
9. [9] B.J. Lum and F.M. Torti, Adjuvant intravesicular pharmacotherapy for superficial bladder cancer, J. Natl. Cancer Inst., 83 (1991) 682-694.
10. [10] M.J. Manayak, Photodynamic therapy: principles and urologic applications. Semin. Urol., 9 (1991) 192-202.
11. [11] A.J. Pope and S.G. Bown, Photodynamic therapy, Br. J. Urol., 68 (1991) 1-9.
12. [12] U.O. Nseyo, Photodynamic therapy, Urol. Clin. North Am., 19 (1992) 591-599.
13. [13] D. Jocham, M. Beer, R. Baumgartner, G. Staehler and E. Unsöld, Long-term experience with integral photodynamic therapy of TIS bladder carcinoma, in G. Bock and S. Harnet (eds.), Photosensitizing Compounds: their Chemistry, Biology and Clinical Use, Ciba Foundation Symposium 146, Wiley, Chichester, 1989, pp. 198-208.
14. [14] J.I. Harty, M. Amin, T.J. Wieman, M.T. Tseng, D. Ackerman and W. Broghamer, Complications of whole bladder dihematoporphyrin ether photodynamic therapy, J. Urol., 141 (1989) 1341-1346.
15. [15] K. Naito, H. Hisazumi, T. Uchibayashi, T. Amano, A. Hirata, K. Komatsu, T. Ishida and N. Miyoshi, Integral laser photodynamic treatment of refractory multifocal bladder tumours, J. Urol., 146 (1991) 1541-1545.
16. [16] M.A. D'Hallewin, L. Baert, J.P.A. Marijnissen and W.M. Star, Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder, J. Urol., 148 (1992) 1152-1155.
17. [17] T. Uchibayashi, K. Koshida, K. Kunimi and H. Hisazumi, Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder, Br. J. Cancer, 71 (1995) 625-628.
18. [18] U.O. Nseyo, S.L. Lundahl and D.C. Merrill, Whole bladder photodynamic therapy: critical review of present-day technology and rationale for development of intravesical laser catheter and monitoring system, Urology, 36 (1990) 398-402.
19. [19] J.P.A. Marijnissen, H. Jansen and W.M. Star, Treatment system for whole bladder wall photodynamic therapy with in vivo monitoring and control of light dose rate and dose, J. Urol., 142 (1989) 1351-1355.
20. [20] E. Unsöld, W. Beyer, A. Heinze and R. Sroka, Irradiation modalities for photodynamic therapy, Lasers Med. Sci. Suppl. (1989) 159-164.
21. [21] E. Unsöld, R. Baumgartner, W. Beyer, D. Jocham and H. Stepp, Fluorescence detection and photodynamic treatment of photosensitized tumours in special consideration of urology, Lasers Med. Sci., 5 (1990) 207-212.
22. [22] J.P.A. Marijnissen, W.M. Star, H.J.A. in 't Zandt, M.A. D'Hallewin and L. Baert, In situ light dosimetry during whole bladder wall photodynamic therapy: clinical results and experimental verification, Phys. Med. Biol., 38 (1993) 567-582.
23. [23] H.J. van Staveren, J.F. Beek, J.W.H. Ramaekers, M. Keijzer and W.M. Star, Integrating sphere effect in whole bladder wall photodynamic therapy. I:532 nm versus 630 nm optical irradiation, Phys. Med. Biol., 39 (1994) 947-959.
24. [24] M.A. D'Hallewin and L. Baert, Long term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder, Urology, 45 (1995) 763-767.
25. [25] D. Jocham, personal communication, 1996.
26. [26] A.J. Pope and S.G. Bown, The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization, J. Urol., 145 (1991) 1064-1070.
27. [27] K. Taari, M. Talja, M. Riihelä, S. Ranniko and R. Mokka, Morphological effects of photodynamic therapy on rabbit bladder using Photofrin II and Photosan intravesically and intravenously, Br. J. Urol., 70 (1992) 616-621.
28. [28] M. Kriegmair, R. Baumgartner, S. Stocker, R. Riesenberg, A. Hofstetter, R. Knüchel and P. Steinbach, Photodynamic therapy of urothelial cancer following intravesical application of 5-aminolevulinic acid in a rat bladder tumour model, J. Urol., 151 (1994) 518A.
29. [29] M. Kriegmair, R. Baumgartner, W. Lumper, R. Waidelich, A. Hofstetter, Early clinical experience with 5-aminolevulinic acid for photodynamic therapy of superficial bladder cancer, submitted to Br. J. Urology.
30. [30] I. Eder, A. Stenzl, H. Kostron, G. Bartsch, H. Klocker, Elektromotive diffusion (EMD) and photodynamic therapy with δ-aminolevulinic acid (ALA) for superficial bladder cancer, J. Urology, 153 (1995) 234A.
31. [31] R. Baumgartner, H. Fisslinger, D. Jocham, H. Lenz, L. Ruprecht, H. Stepp and E. Unsöld, A fluorescence imaging device for endoscopic detection of early stage cancer-instrumental and experimental studies, Photochem. Photobiol., 46 (1987) 759-763.
32. [32] L. Baert, R. Berg, B. van Damme, M.A. D'Hallewin, J. Johansson, K. Svanberg and S. Svanberg, Clinical fluorescence diagnosis of human bladder carcinoma following low dose Photofrin injection, Urology, 41 (1993) 322-330.
33. [33] M. Kriegmair, R. Baumgartner, W. Lumper, R. Riesenberg, S. Stocker and A. Hofstetter, Fluorescence cystoscopy following intravesical instillation of aminolevulinic aid (ALA), J. Urol., 149 (1993) 240A.
34. [34] M. Kriegmair, R. Baumgartner, R. Knüchel, H. Stepp, F. Hofstädter, A. Hofstetter, Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence, J. Urology, in press.
35. [35] J.B. Mitchell et al., Biological basis for phototherapy, in G. Morstyn and A.H. Kaye (eds.), Phototherapy of Cancer, Harwood Academic Publishers, Chur, 1990, pp. 1-22.
36. [36] H. Kato et al., Photodynamic therapy of early-stage lung cancer, in G. Bock and S. Harnet (eds.), Photosensitizing compounds: their chemistry biology and clinical use, Ciba Foundation Symposium 146, Wiley, Chichester, 1989, pp. 183-194.
37. [37] H. Kato, Photodynamic therapy of early cancer, in G. Morstyn, A.H. Kaye, (eds.), Phototherapy of Cancer, Harwood Academic Publishers, Chur, 1990, pp. 133-151.
38. [38] D.A. Cortese and J.H. Kinsey, Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy, Mayo Clin. Proc., 57 (1982) 543-547.
39. [39] E.S. Edell and D.A. Cortese, Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a five-year experience, Mayo Clin. Proc., 62 (1987) 8-14.
40. [40] E.S. Edell and D.A. Cortese, Bronchoscopic localization and treatment of occult lung cancer, Chest, 96 (1989) 919-924.
41. [41] G. Sutedja, P. Baas, F.A. Stewart and N. van Zandwijk, A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer, Eur. J. Cancer, 28a (1992) 1370-1373.
42. [42] K. Furuse, M. Fukuoka, H. Kato et al., A prospective phase II study on photodynamic therapy with Photofrin II for centrally located early-stage lung cancer, J. Clin. Oncol., 11 (1993) 1852-1857.
43. [43] N. van Zandwijk, T. Sutedja, P. Baas and F. Stewart, An emerging role for photodynamic therapy in lung cancer, Form. Trends Exp. Clin. Med., 3 (1993) 33-39.
44. [44] T.J. Dougherty et al., Cutaneous phototoxic occurrences in patients receiving photofrin, Lasers Surg. Med., 10 (1990) 485-488.
45. [45] J.S. McCaughan, J.T. Guy, W. Hicks, L. Laufman, T.A. Nims and J. Walker, Photodynamic Therapy for Cutaneous and Subcutaneous Malignant Neoplasms, Arch. Surg., 125 (1989) 211-216.
46. [46] P.J. Robinson, J.A.S. Carruth and G.M. Fairris, Photodynamic therapy: a better treatment for widespread Bowen's disease, Br. J. Dermatol., 119 (1988) 59-61.
47. [47] C. Jones, M. Cooper, T. Mang, B.D. Wilson and H.L. Stoll, Photodynamic Therapy in the Treatment of Unusual Bowen's Disease, J. Am. Acad. Dermatol., 27 (1992) 979-982.
48. [48] B.D. Wilson, T.S. Mang, M. Cooper and H. Stoll, Use of Photodynamic Therapy for the Treatment of Extensive Basal Cell Carcinomas, Facial Plast. Surg., 6 (1989) 185-189.
49. [49] D.G. Pennington, M. Waner and A. Knox, Photodynamic Therapy for Multiple Skin Cancers, Plast. Reconstr. Surg., 82 (1988) 1067-1071.
50. [50] J.S. McCaughan Jr., J.T. Guy, W. Hicks, L. Laufman, T.A. Nims and J. Walker, Photodynamic Therapy for cutaneous and subcutaneous malignant neoplasms, Arch. Surgery, 124 (2), (1989) 211-216.
51. [51] D. Gilson, D. Ash, I. Drirer, J.W. Feather and S. Brown, Therapeutic ratio of Photodynamic Therapy in the Treatment of Superficial Tumours of Skin and Subcutaneous Tissues in Man, Br. J. Cancer, 68 (1988) 665-667.
52. [52] D.J. Gross, M. Waner, R.H. Schosser and S.M. Dinehart, Squamous Cell Carcinoma of the Lower Lip Involving a Large Cutaneous Surface, Photodynamic Therapy as an Alternative Therapy, Arch. Dermatol., 126 (1990) 1148-1150.
53. [53] T.J. Dougherty, Photoradiation Therapy for Cutaneous and Subcutaneous Malignancies, J. Invest. Dermatol., 77 (1981) 122-124.
54. [54] G. Bandieramonte, R. Marchesini, E. Melloni, C. Andreoli, S. di Pietro, P. Spinelli, G. Fava, F. Zunino and H. Emanuelli, Laser Phototherapy Following HpD Administration in Superficial Neoplastic Lesions, Tumouri, 70 (1984) 327-334.
55. [55] M. Shuh, U.O. Nseyo, W.R. Potter, T.L. Dao and T.J. Dougherty, Photodynamic Therapy for Palliation of Locally Recurrent Breast Carcinoma, J. Clin. Oncol., 5 (1987) 1766-1770.
56. [56] V.G. Schweitzer, D. Visscher, Photodynamic Therapy for Treatment of AIDS-related Oral Kaposi's Sarcoma, Otolaryngol. Head Neck Surg., 102 (1990) 639-649.
57. [57] J.L. McCullogh, G.D. Weinstein, J.L. Douglas and M.W. Berns, Photosensitizers in dermatology, Photochem. Photobiol., 46 (1987) 77-82.
58. [58] G.D. Weinstein, J.L. McCullough, J.S. Nelson and M.W. Berns, Low dose Photofrin II photodynamic therapy of psoriasis, J. Invest. Dermatol., 96 (1991) 573.
59. [59] A.L. Abramson, M.J. Shikowitz, V.M. Mullooly, B.M. Steinberg, C.A. Amella and H.R. Rothstein, Clinical effects of photodynamic therapy on recurrent laryngeal papillomas, Arch. Otolaryngol. Head Neck Surg., 118 (1992) 25-29.
60. [60] O. Santoro, G. Bandieramonte, E. Melloni, R. Marchesini, F. Zunino, P. Lepera and G. De Palo, Photodynamic therapy by topical metetetraphenylporphinesulphonate tetrasodium salt administration in superficial basal cell carcinomas. Cancer Res., 50 (1990) 4501-4503.
61. [61] J.C. Kennedy and R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol., 14 (1992) 275-292.
62. [62] P. Wolf, E. Rieger and H. Kerl, Topical photodynamic therapy with endogeneous porphyrins after application of 5-aminolevulinic acid, J. Am. Acad. Derm., 28(1) (1993) 17-21.
63. [63] F. Cairnduff, M.R. Stringer, E.J. Hudson, D.V. Ash and S.B. Brown, Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer, Br.J. Cancer, 69 (1994) 605-608.
64. [64] K. Svanberg, T. Anderson, D. Killander, I. Wang, U. Stenram, S. Andersson-Engels, R. Berg, J. Johansson and S. Svanberg, Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation, Br. J. Dermatol., 130 (1994) 743-751.
65. [65] H. Lui, N. Kollias, J. Wimberly, S. Salasche, D. McLean and R. Anderson, Photodynamic therapy of nonmelanoma skin cancer with 5-aminolevulinic acid and visible light: a clinical and histological study, Proc. Ann. Meet. Am. Soc. Photobiol., (1994) 59s, 71s.
66. [66] S.D. Shanler, W. Wan, J.E. Whitaker, T.S. Mang, C. Jones, B.D. Wilson, H. Stoll and A.R. Oseroff, Photodynamic therapy with topical δ-aminolevulinic acid for treatment of cutaneous carcinomas and cutaneous T-cell lymphoma, J. Invest. Dermatol., 101 (1993) 406a.
67. [67] P. Wolf, R. Fink-Puches, L. Cerroni and H. Kerl, Photodynamic therapy for mycosis fungoides after topical photosensitisation with 5-aminolevulinic acid, J. Am. Acad. Derm., 31 (1994) 678-680.
68. [68] D.R. Gnepp (ed.), Pathology of the Head and Neck, Churchill, Livingstone, New York, 1988, pp. 266-284.
69. [69] J.G. Batsakis (ed.), Tumours of the Head and Neck. Clinical and Pathological Considerations, 2nd edn., William and Wilkins, Baltimore, M.D., 1979, pp. 144-177.
70. [70] D.P. Slaughter, H.W. Southwick and W. Smejkal, "Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer, 6 (1953) 963-968.
71. [71] N. de Vries, Second primary tumours in laryngeal cancer, Acta Otorhinolaryngol.-Belg., 46 (1992) 153-159.
72. [72] N. de Vries, I. van de Waal and G.B. Snow, Multiple primary tumours in oral cancer, Int. J. Oral Maxillofac. Surg., 15 (1986) 85-87.
73. [73] R. Pasche, M. Savary and Ph. Monnier, Multiple squamous cell carcinoma of the upper digestive and lower respiratory tracts: methodology of endoscopic screening, Acta Endoscopica, 11 (1981) 277-291.
74. [74] A.G. Wile, A. Dahlman A, R.G. Burns and M.W. Berns, Laser photoradiation therapy of cancer following hematoporphyrin sensitization, Lasers Surg. Med., 2 (1982) 107-127.
75. [75] A. Dahlman, A.G. Wile, R.G. Burns, R. Mason, F.M. Johnson and M.W. Berns, Laser photoradiation therapy of cancer, Cancer Res., 43 (1983) 430-434.
76. [76] L.I. Grossweiner, J.H. Hill, R.V. Lobraico, Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial, Photochem. Photobiol., 46 (1987) 911-917.
77. [77] G.S. Keller, D.R. Doiron and G.U. Fisher, Photodynamic therapy in otolaryngology- Head and Neck Surgery, Arch. Otolaryngol., 111 (1985) 758-761.
78. [78] D.E. Schuller, J.S. McCaughan and R.P. Rock, Photodynamic therapy in head and neck cancer, Arch. Otolaryngol., 111 (1985) 351-355.
79. [79] J.L. Gluckman, Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections of a 5 year experience, Laryngoscope, 101 (1991) 36-42.
80. [80] C. Freche and S. De Corbiere, Use of photodynamic therapy in the treatment of vocal cord carcinoma, J. Photochem. Photobiol. B: Biol., 6 (1990) 291-296.
81. [81] Ph. Monnier, M. Savary, Ch. Fontolliet, G. Wagnieres, A. Chatelain, P. Cornaz, Ch. Depeursinge and H. van den Bergh, Photodetection and photodynamic therapy of "early" squamous cell carcinoma of the pharynx, oesophagus and tracheo-bronchial tree, Lasers Med. Sci., 5 (1990) 149-169.
82. [82] K. Moghissi, K. Dixon, E. Hudsun and M. Stringer, Photodynamic therapy (PDT) of Oesophageal cancer, Lasers Med. Sci., 10 (1995) 67-71.
83. [83] M.A. Biel, Photodynamic therapy and the treatment of primary malignancies of the head and neck, in 5th. Int. Photodynamic Association Biennial Meeting, September 21-24, 1994, FL, USA, Abstract 100.
84. [84] B. Overholt, M. Panjehpour, E. Tefftelar and M. Rose, Photodynamic therapy for treatment of early adenocarcinoma in Barret's esophagus, Gastrointest. Endoscop., 39, (1) (1993) 73-76.
85. [85] H.G. Schmidt, R.H. Riddell, B. Walter, D.B. Skinner and J.F. Riemann, Dysplasia in Barret's esophagus, J. Cancer Res. Clin. Oncol., 110 (1985) 145-152.
86. [86] H. Barr, T. Dix, D. Roberts and N. Shepard, Eradication of high grade dysplasia in columnar lined (Barret's) oesophagus by photodynamic therapy with oral 5-aminolevulinic acid and 630 nm light, Gut, 35, (Suppl. 5), (1994) 7.
87. [87] J.F. Savary, Ch. Fontolliet, D. Braichotte, Ph. Monnier and H. van den Bergh, Detection by fluorescence microscopy of the localization and time dependent mTHPC. Distribution in biopsies of bronchi, oesophagus and pharynx, in 5th Int. Photodynamic Association Biennial Meeting, September 21-24, 1994, FL, USA, Abstract, p. 37.
88. [88] J.F. Savary, Ch. Fontolliet, D. Braichotte, Ph. Monnier and H. van den Bergh, First clinical results after photodynamic treatment of early squamous cell carcinomas of the oesophagus, bronchi and mouth with meta-tetrahydroxyphenyl chlorin (m-THPC), in 5th Int. Photodynamic Association Biennial Meeting, September 21-24, 1994, FL, USA, Abstract 27.
89. [89] Ph. Monnier, J.F. Savary, G. Wagnieres, H. van den Bergh, J. Mizeret and Ch. Fontolliet, Green light (514 nm) irradiation for the prevention of complications in PDT of early squamous cell carcinomas of the oesophagus, in 5th Int. Photodynamic Association Biennial Meeting, September 21-24, 1994, FL, USA, Abstract 28.
90. [90] M.G. Dilkes and M.L. DeJode, m-THPC mediated PDT. Experience and thoughts after 17 treatments, in D.A. Cortese (ed.) 5th Int. Photodynamic Association Biennial Meeting, Proc. SPIE., 2371 (1995) 256-261.
91. [91] W.E. Grant, C. Hopper, A.J. MacRobert, P.M. Speight and S.G. Bown, Photodynamic therapy of oral cancer: photosensitization with systemic aminolaevulinic acid, Lancet, 342 (1993) 147-148.
92. [92] C. Hopper, K. Fan, W.E. Grant, P.M. Speight and S.G. Bown, Photodynamic therapy using 5-aminolaevulinic acid in oral malignancy and premalignancy, in D.A. Cortese (ed.), 5th Int. Photodynamic Association Biennial Meeting, Proc. SPIE, 2371 (1995) 254-255.
93. [93] M.A. Biel, Photodynamic therapy and the treatment of neoplastic diseases of the larynx, Laryngoscope, 104 (1994) 399-403.
94. [94] M.A. Biel, Photodynamic tyherapy as an adjuvant intraoperative treatment of recurrent head and carcinomas, in 5th Int. Photodynamic Association Biennial Meeting, September 21-24, 1994 FL, USA, Abstract 101.
95. [95] A.L. Abramson, M.J. Shikowitz, V.M. Mullooly, B.M. Steinberg and R.B. Hyman, Variable light dose effects on photodynamic therapy for laryngeal papillomas, Arch. Otolaryngol. Head and Neck Surg., 120 (1994) 852-855.
96. [96] J. Feyh, A. Gutmann and A. Leunig, Photodynamic therapy in head and neck surgery, Laryngo Rhino Otol., 72 (1993) 273-278.
97. [97] J. Feyh, Photodynamic therapy of malignant and nonmalignant tumours in head and neck surgery. Results of a clinical study, in 5th Int. Photodynamic Association Biennial Meeting, September 21-24 1994, FL, USA, Abstract 103.
98. [98] T.J. Dougherty, Photodynamic therapy for early stage lung cancer, Chest, 102 (5), (1992) 1314-1315.
99. [99] J.G. Levy, The preclinical and clinical development of Photofrin® and benzoporphyrin derivative: A reflection on opportunities and challenges, J. Photochem. Photobiol. B: Biol., 30 (1995) 79-82.